The inverse relationship between zinc (Zn//) and prolactin (PRL) was detected in in vitro studies, whereas in vivo results are contradictory. In order to evaluate this controversial subject we studied patients with hyperprolactinemia. Basal 
Introduction
Zn plays an important role in animal and human metabolism, as a constituent or activating cofactor of more than 300 different enzymes. The [4,.6 ]. An inverse relationship between serum Zn+/and plasma PRL levels is a common finding in human chronic renal failure. The administration of oral Zn to a group of uremic hypozincemic men decreased their high PRL levels and these levels were inversely correlated to serum Zn concentrations [7] . In normal male and female subjects and in lambs, acute Zn administration decreased plasma PRL levels [.] , although in another report a similar effect was not observed in normal and hyperprolactinemic women [9] . Furthermore, Travaglini et (Table III) . Again, no significant correlation was detected between Zn /+ and PRL (r -0.25, p > 0.05). In a previous study we have shown that oral Zn+/administration to normal male and female individuals induced a significant decrease in PRL levels, suggesting that acute hyperzincemia can inhibit basal PRL secretion [2] . These data support the hypothesis of Koppelman [11] that PRL regulates the uptake and distribution of Zn +/ and that PRL suppression by this element could represent a negative feedback loop in a similar manner to calcium and PTH. In this study, our patients with hyperprolactinemia showed lower basal serum Zn // levels ( In summary, the present study has shown hypozincemia and no inhibition of TRH-induced PRL secretion during acute and chronic Zn +/ administration in hyperprolactinemic patients. The fact that zinc administration does not inhibit PRL levels argues against the proposal of using zinc as a therapeutical agent in the treatment of hyperprolactinemic patients.
